مقارنة لقاحات كوڤيد-19

مقارنة لقاحات كوڤيد-19.

يستعرض المقال مقارنة بين لقاحات كوڤيد-19.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

مقارنة لقاحات كوڤيد-19

اللقاحات المصرح لها بالاستخدام الطاريء أو الكامل
مطور/راعي اللقاح بلد المنشأ النع (التكنولوجيا) الجرعات، الفترات الفاصلة درجة حرارة التهزين المرحلة الحالية (المشاركون) التصريح
لقاح فايزر-بيون‌تك (Comirnaty)[1][2][3]
بيون‌تك، فايزر 		الولايات المتحدة، ألمانيا الرنا (modRNA في الجسيمات النانوية الدهنية)[1] 2 جرعة
3 – 4 أسابيع[4][أ] 		-70±10 °س[ب]
(ULT) 		المرحلة 3 (43,448)
عشوائية، خاضعة للتحكم الوهمي.
لقاح سپوتنيك ڤ
معهد گماليا لأبحاث علم الأوبئة وعلم الأحياء الدقيقة 		روسيا ناقل ڤيروسي غداني (مؤشب Ad5 وAd26)[70] 2 جرعة
3 أسابيع [71] 		-18 °س[ث]
(المجمد) 		المرحلة 3 (40,000)
عشوائية مزدوجة التعمية، تحت سيطرة وهمية لتقييم الفعالية، والمناعة، والسلامة.[73]
لقاح أكسفورد-أسترازِنـِكا (Covishield)[ج][ح][125][126][127]
جامعة أكسفورد، أسترازِنـِكا، CEPI 		المملكة المتحدة، السويد ناقل ڤيروسي غداني (ChAdOx1)[125] 2 جرعة
4 – 12 أسبوع [128] 		2 – 8 °س[129] المرحلة 3 (30٬000)
تدخلية، عشوائية، تحت سيطرة وهمية للتقييم الفعالية، والمناعة، والسلامة.[130]
BBIBP-CorV[186]
سينوفارم: معهد بكين للمنتجات الحيوية، معهد ووهان للمنتجات الحيوية 		الصين سارس‑كوڤ‑2 خامل (خلايا ڤيرو)[186] 2 جرعة
3 – 4 أسابيع[187] 		2 – 8 °س[188] المرحلة 3 (48٬000)
عشوائية، مزدوجة التعمية، موازية، تحت سيطرة وهمية، لتقييم السلامة والفعالية الوقائية.
كوروناڤاك[214][215][216]
سينوڤاك 		الصين سارس‑كوڤ‑2 [[لقاح خامل|خامل (خلايا ڤيرو)[214] 2 جرعة
2 أسبوع [217] 		2 – 8 °س[218] المرحلة 3 (33,620)
مزدوجة التعمية، عشوائية، خاضعة للتحكم الوهمي لتقييم الفعالية والسلامة.
لقاح مودرنا[236][237]
مودرنا، NIAID، BARDA، CEPI 		الولايات المتحدة رنا (modRNA في الجسيمات الدهنية)[238] 2 جرعة
4 أسابيع [239][أ] 		-20±5 °س[240]
(المجمد) 		المرحلة 3 (30٬000)
تدخلية؛ دراسة عشوائية تحت سيطرة وهمية، من أجل الفعالية والسلامة والمناعة.
لقاح جونسون أند جونسون[256][257]
يانسن للأدوية (جونسون أند جونسون)، BIDMC 		الولايات المتحدة، هولندا ناقل ڤيروسي غداني (مؤشب Ad26)[258] 1 جرعة [259] 2 – 8 °س [259] المرحلة 3 (40,000)
عشوائية، مزدوجة التعمية، تحت سيطرة وهمية.
BBV152 (Covaxin)
بارات بيوتك، المجلس الهندي للأبحاث الطبية 		الهند سارس‑كوڤ‑2 خامل (خلايا ڤيرو)[272] 2 جرعة
4 أسابيع [273] 		2 – 8 °س[273] المرحلة 3 (25٬800)
عشوائية، مراقبة-معماة، تحت سيطرة وهمية.[274]
Ad5-nCoV (Convidicea)
كان‌سينو، بيولجيكس، معهد بكين للتقنية الحيوية 		الصين ناقل ڤيروسي غداني مؤشب Ad5)[277] 1 جرعة[278] 2 – 8 °س[278] المرحلة 3 (40,000)
عالمية متعددة المراكز، عشوائية، مزدوجة التعمية، تحت سيطرة وهمية لتقييم الفعالية والسلامة والمناعة.
إپي‌ڤاك‌كورونا[282]
معهد ڤكتور 		روسيا وحدة فرعية (پپتيدي)[282] 2 جرعة
3 – 4 أسابيع[282] 		2 – 8 °س[283] المرحلة 3 (40,000)
عشوائية مزدوجة التعمية، تحت سيطرة وهمية لتقييم الفعالية، والمناعة، والسلامة.
ru (CoviVac)[288]
مركز تشوماكوڤ في الأكاديمية الروسية للعلوم 		روسيا سارس‑كوڤ‑2 خامل[289] 2 جرعة
2 أسبوع [290] 		2 – 8 °س[290] المرحلة 3 (3٬000)
مزدوجة التعمية، عشوائية، تحت سيطرة وهمية لتقييم الفعالية والسلامة.
ZF2001 (RBD-دايمر)[292]
آن‌هوي ژي‌فيْ لونگكوم للأدوية 		الصين وحدة فرعية (مؤشب) 3 جرعات
30 يوم[293][294] 		المرحلة 3 (29,000)
عشوائية، مزدوجة التعمية، تحت سيطرة وهمية[293]


انظر أيضاً

المصادر

  1. ^ أ ب ت "Regulatory Decision Summary – Pfizer-BioNTech COVID-19 Vaccine". Health Canada, Government of Canada. 9 December 2020. Retrieved 9 December 2020.
  2. ^ "Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults". ClinicalTrials.gov. United States National Library of Medicine. 30 April 2020. NCT04368728. Archived from the original on 11 October 2020. Retrieved 14 July 2020.
  3. ^ "A Multi-site Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-19 Using Different Dosing Regimens in Healthy Adults". EU Clinical Trials Register. European Union. 14 April 2020. EudraCT 2020-001038-36. Archived from the original on 22 April 2020. Retrieved 22 April 2020.
  4. ^ Farge, Emma; Revill, John (5 January 2021). "WHO recommends two doses of Pfizer COVID-19 vaccine within 21–28 days". Reuters. Geneva. Retrieved 5 March 2021.
  5. ^ Keaten, Jamey (8 January 2021). "WHO: Amid short supplies, vaccine doses can be 6 weeks apart". Associated Press. Geneva. Retrieved 6 March 2021.
  6. ^ "COVID vaccine: Moderna shots can be 6 weeks apart, WHO says". Deutsche Welle. 26 January 2021. Retrieved 6 March 2021.
  7. ^ "Coronavirus (COVID-19) Update: FDA Allows More Flexible Storage, Transportation Conditions for Pfizer-BioNTech COVID-19 Vaccine" (Press release). Food and Drug Administration (FDA). 25 February 2021. Retrieved 5 March 2021.
  8. ^ أ ب "Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers" (PDF). Pfizer. 25 February 2021. Retrieved 25 February 2021.
  9. ^ "Albania to start COVID-19 immunisation with Pfizer vaccine in January – report". Seenews.
  10. ^ "ANDORRA COVID-19". govern.ad. Retrieved 19 February 2021.
  11. ^ "Coronavirus en la Argentina: La ANMAT aprobo el uso de emergencia de la vacuna Pfizer". La Nación (in الإسبانية). Retrieved 23 December 2020.
  12. ^ Overheid, Aruba (7 January 2021). "COVID-19 vaccine update". government.aw. Retrieved 19 February 2021.
  13. ^ "Bahrain becomes second country to approve Pfizer COVID-19 vaccine". Al Jazeera. Retrieved 5 December 2020.
  14. ^ أ ب ت "Drug and vaccine authorizations for COVID-19: List of applications received". Health Canada, Government of Canada. 9 December 2020. Retrieved 9 December 2020.
  15. ^ "Pfizer vaccine approved for region but Health Ministry wants more info". Trinidad and Tobago Newsday. 6 January 2021. Retrieved 24 February 2021.
  16. ^ "Chile approves Pfizer-BioNTech Covid-19 vaccine for emergency use". The Straits Times. 17 December 2020. Retrieved 17 December 2020.
  17. ^ "Colombia regulator approves Pfizer-BioNTech vaccine for emergency use". Reuters. 6 January 2021. Retrieved 6 January 2021.
  18. ^ "Costa Rica authorizes Pfizer-BioNTech coronavirus vaccine". The Tico Times. 16 December 2020. Retrieved 16 December 2020.
  19. ^ "Arcsa autoriza ingreso al país de vacuna Pfizer-BioNTech para el Covid-19 – Agencia Nacional de Regulación, Control y Vigilancia Sanitaria" (in الإسبانية). Retrieved 17 December 2020.
  20. ^ "Use of vaccine approved". Government of Hong Kong. 25 January 2021. Retrieved 15 February 2021.
  21. ^ "Iraq grants emergency approval for Pfizer COVID-19 vaccine". MSN. Retrieved 27 December 2020.
  22. ^ "Israeli Health Minister 'pleased' as FDA approves Pfizer COVID-19 vaccine". The Jerusalem Post. Retrieved 28 December 2020.
  23. ^ "Jordan approves Pfizer-BioNTech Covid vaccine". France 24. 15 December 2020. Retrieved 15 December 2020.
  24. ^ "Kuwait authorizes emergency use of Pfizer-BioNTech COVID-19 vaccine". Arab News. 13 December 2020. Retrieved 15 December 2020.
  25. ^ "Liechtenstein – COVID19 Vaccine Tracker". covid19.trackvaccines.org. Retrieved 19 February 2021.
  26. ^ "Mexico Approves Pfizer Vaccine for Emergency Use as Covid Surges". Bloomberg. 12 December 2020. Retrieved 12 December 2020.
  27. ^ "Mexico authorizes emergency use of Pfizer-BioNTech coronavirus vaccine". The Economic Times. 12 December 2020. Retrieved 14 January 2021.
  28. ^ "FIRST VACCINES ARRIVE IN MONACO – COVID-19 vaccination campaign begins tomorrow / Actualités / Coronavirus (Covid-19) / Policy & Practice / Portail du Gouvernement – Monaco". en.gouv.mc. Retrieved 19 February 2021.
  29. ^ "Robust assessment ahead of Medsafe approval of vaccine". Ministry of Health. 3 February 2021. Retrieved 6 February 2021.
  30. ^ "North Macedonia Kicks Off COVID-19 Vaccinations As Serbia Looks To Highlight Regional Efforts". RadioFreeEurope/RadioLiberty. Retrieved 19 February 2021.
  31. ^ "Oman issues licence to import Pfizer BioNTech Covid vaccine – TV". Reuters. 15 December 2020. Retrieved 16 December 2020.
  32. ^ "Panama approves Pfizer's COVID-19 vaccine – health ministry". Yahoo! Finance. Retrieved 16 December 2020.
  33. ^ "PH authorizes Pfizer's COVID-19 vaccine for emergency use". CNN Philippines. 14 January 2021. Retrieved 14 January 2021.
  34. ^ "Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this week". Reuters. Retrieved 24 December 2020.
  35. ^ أ ب ت ث ج "Public Health (Emergency Authorisation of COVID-19 Vaccine) Rules, 2021" (PDF). Government of Saint Vincent and the Grenadines. 11 February 2021. Retrieved 12 February 2021.
  36. ^ "Singapore approves use of Pfizer's COVID-19 vaccine". AP NEWS. 14 December 2020. Retrieved 15 December 2020.
  37. ^ "Suriname begins coronavirus vaccination campaign with donated doses". Reuters. 23 February 2021. Retrieved 28 February 2021.
  38. ^ "Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland" (Press release). Swiss Agency for Therapeutic Products (Swissmedic). 19 December 2020. Retrieved 19 December 2020.
  39. ^ "Comirnaty Product information" (in الألمانية). Retrieved 31 January 2021. [Due to incomplete clinical data at the time of the assessment of the authorization application, the Comirnaty medicinal product is authorized for a limited period (Art. 9a Medicinal Products Act).]
  40. ^ "Dubai approves the Pfizer-BioNTech vaccine which will be free of charge". Emirates Woman. 23 December 2020. Retrieved 28 December 2020.
  41. ^ Decree of Ministry of Health of Ukraine on approval Covishield and Comirnaty vaccines
  42. ^ "UK medicines regulator gives approval for first UK COVID-19 vaccine". Medicines and Healthcare Products Regulatory Agency, Government of the UK. 2 December 2020. Retrieved 2 December 2020.
  43. ^ "Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine". Medicines & Healthcare products Regulatory Agency (MHRA). 8 December 2020. Retrieved 13 December 2020.
  44. ^ "Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine". Medicines & Healthcare products Regulatory Agency (MHRA). 3 December 2020. Retrieved 13 December 2020.
  45. ^ "Interior Applauds Inclusion of Insular Areas through Operation Warp Speed to Receive COVID-19 Vaccines" (Press release). United States Department of the Interior (DOI). 12 December 2020. Retrieved 13 January 2021.  هذا المقال يضم نصاً من هذا المصدر، الذي هو مشاع.
  46. ^ Dorman B (6 January 2021). "Asia Minute: Palau Administers Vaccines to Keep Country Free of COVID". Hawaii Public Radio. Retrieved 13 January 2021.
  47. ^ "FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine" (Press release). U.S. Food and Drug Administration (FDA). 11 December 2020. Retrieved 11 December 2020.  هذا المقال يضم نصاً من هذا المصدر، الذي هو مشاع.
  48. ^ McElwee, Joshua J. (11 December 2020). "Vatican to offer coronavirus vaccine to residents and staff in early 2021". National Catholic Reporter. Retrieved 9 February 2021.
  49. ^ Menichetti, Massimiliano (11 December 2020). "In Vaticano parte il piano vaccinale anticovid". vatican.va (Press release). Retrieved 9 February 2021.
  50. ^ أ ب "Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process" (PDF). World Health Organization (WHO).
  51. ^ "WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access". World Health Organization (WHO) (Press release). 31 December 2020. Retrieved 6 January 2021.
  52. ^ "Comirnaty". Therapeutic Goods Administration. 25 January 2021. Retrieved 25 January 2021.
  53. ^ Australian Public Assessment Report for BNT162b2 (mRNA). Therapeutic Goods Administration (TGA). Archived from the original. You must specify the date the archive was made using the |archivedate= parameter. https://www.tga.gov.au/sites/default/files/auspar-bnt162b2-mrna-210125.pdf. Retrieved on 25 January 2021. 
  54. ^ "Vacina da Pfizer é a 1ª a obter registro definitivo no Brasil" (in البرتغالية البرازيلية). G1. 23 February 2021. Retrieved 23 February 2021.
  55. ^ "Comirnaty EPAR". European Medicines Agency (EMA). Retrieved 23 December 2020.
  56. ^ "Questions and Answers: COVID-19 vaccination in the EU". European Commission. 21 December 2020. Retrieved 21 December 2020.
  57. ^ "Comirnaty". Union Register of medicinal products. Retrieved 8 January 2021.
  58. ^ أ ب "Første vaccine mod COVID19 godkendt i EU". Lægemiddelstyrelsen (in الدانمركية). Retrieved 26 December 2020.
  59. ^ "COVID-19: Bóluefninu Comirnaty frá BioNTech/Pfizer hefur verið veitt skilyrt íslenskt markaðsleyfi". Lyfjastofnun (in الأيسلندية). Retrieved 26 December 2020.
  60. ^ "Japan approves Pfizer's COVID-19 vaccine, 1st for domestic use". Nikkei Asia. 14 February 2021. Retrieved 14 February 2021.
  61. ^ "Malaysia's NPRA Approves Pfizer Covid-19 Vaccine". CodeBlue. 8 January 2021. Retrieved 25 February 2021.
  62. ^ Lim I (8 January 2021). "Khairy: Malaysia can use Pfizer's Covid-19 vaccine now as conditional registration granted". The Malay Mail. Retrieved 8 January 2021.
  63. ^ "Status på koronavaksiner under godkjenning per 21.12.20". Statens legemiddelverk (in النرويجية بوكمال). Retrieved 26 December 2020.
  64. ^ "Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use". Al Arabiya English. 10 December 2020. Retrieved 10 December 2020.
  65. ^ Zimmer C, Corum J, Wee S (10 June 2020). "Coronavirus Vaccine Tracker". The New York Times. Retrieved 12 December 2020.
  66. ^ "Serbia leads region in expecting COVID-19 vaccines within days". BalkanInsight. 21 December 2020. Retrieved 26 December 2020.
  67. ^ "First shipment of Pfizer-BioNTech vaccine arrives in Serbia". Serbian government website. 22 December 2020. Retrieved 26 December 2020.
  68. ^ Lee, Kyung-eun (27 February 2021). "S. Korea begins rolling out Pfizer vaccines on second day of national vaccination program". Arirang News. Retrieved 28 February 2021.
  69. ^ Kim, Han-joo (5 March 2021). "S. Korea approves Pfizer's COVID-19 vaccine amid immunization push". Yonhap News Agency. Retrieved 5 March 2021.
  70. ^ "An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19". ClinicalTrials.gov. United States National Library of Medicine. 17 June 2020. NCT04436471. Retrieved 5 March 2021.
  71. ^ Jones, Ian; Roy, Polly (2 February 2021). "Sputnik V COVID-19 vaccine candidate appears safe and effective". The Lancet. 397 (10275): 642–643. doi:10.1016/S0140-6736(21)00191-4. PMC 7906719. PMID 33545098.
  72. ^ Sagdiev, Rinat; Ivanova, Polina (16 November 2020). "Russia focuses on freeze-dried vaccine doses as transport fix". Reuters. Moscow. Retrieved 5 March 2021.
  73. ^ "Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19". ClinicalTrials.gov. Archived from the original on 12 September 2020. Retrieved 11 September 2020.
  74. ^ "Covid19: National Pharmaceuticals Agency registers Sputnik V vaccine". Algeria Press service. 10 January 2021.
  75. ^ "Argentina has registered the Sputnik V vaccine based on Russian clinical trial data" (Press release). Gamaleya Center. Retrieved 1 January 2021.
  76. ^ "Armenia approves Russia's Sputnik V coronavirus vaccine -Russia's RDIF". Reuters. 1 February 2021. Retrieved 1 February 2021.
  77. ^ "Bahrain authorises Sputnik V COVID-19 vaccine for emergency use – Bahrain TV". Reuters. 10 February 2021. Retrieved 19 February 2021.
  78. ^ "Belarus registers Sputnik V vaccine, in first outside Russia – RDIF". Reuters. 21 December 2020. Retrieved 22 December 2020.
  79. ^ "Ministerio de Salud de Bolivia – Bolivia y Rusia firman contrato para adquirir 5,2 millones de dosis de la vacuna Sputnik-V contra la COVID-19". minsalud.gob.bo. Retrieved 1 January 2021.
  80. ^ أ ب "COVID-19: Egypt authorises Sputnik V, AstraZeneca virus jabs". Gulf News. Retrieved 24 February 2021.
  81. ^ "Sputnik V authorised in Gabon" (Press release). Gamaleya Center. Retrieved 17 February 2021.
  82. ^ "Ghana approves Russia's Sputnik V vaccine for emergency use – RDIF". Reuters. 20 February 2021.
  83. ^ "Guatemala to receive Russia's Sputnik vaccine in coming weeks". Reuters. 24 February 2021.
  84. ^ "Guinea Begins Administering Russia's Sputnik V Covid-19 Vaccine". Africa news. 31 December 2020.
  85. ^ "Russia's Sputnik V vaccine expands its reach in Latin America". CNN. 3 March 2021.
  86. ^ "Honduras approves use of Sputnik V vaccine against COVID-19". Xinhua News Agency. 25 February 2021.
  87. ^ "Iran approves Russian coronavirus vaccine Sputnik V". Reuters. 26 January 2021.
  88. ^ "Sputnik V authorized in Iraq" (Press release). PharmiWeb.com. 4 March 2021.
  89. ^ "Jordan approves Russia's Sputnik V vaccine for use against COVID-19" (Press release). Reuters. 10 March 2021.
  90. ^ "Kazakhstan begins mass vaccination by Russian Sputnik V". 1 February 2021. Retrieved 19 February 2021.
  91. ^ "Morocco, Kenya approve Russian coronavirus vaccine for use - RDIF". 10 March 2021. Retrieved 12 March 2021.
  92. ^ أ ب "Laos declares Covid-19 vaccinations safe, more to be inoculated next week | The Star". The Star. Malaysia. Retrieved 19 February 2021.
  93. ^ "Lebanon authorises emergency use of Russia's Sputnik V vaccine". Reuters. 5 February 2021.
  94. ^ "Mexico, Germany warm to Russia's Sputnik V virus vaccine". The Jakarta Post. 3 February 2021.
  95. ^ "Mongolia Approves Russia's Sputnik V Coronavirus Vaccine – RDIF". Urdu Point. 9 February 2021.
  96. ^ "Montenegro and St. Vincent approve Russia's Sputnik V vaccine – RDIF". Reuters. 12 February 2021.
  97. ^ "Morocco orders one million doses of Russia's Sputnik V vaccine". Yabiladi. 11 March 2021.
  98. ^ "Myanmar registers Russia's Sputnik V COVID-19 vaccine". TASS. Retrieved 19 February 2021.
  99. ^ "Nicaragua approves Russian COVID-19 vaccine". wsoctv. 3 February 2021.
  100. ^ "NRussia's Sputnik V COVID 19 vaccine registered in North Macedonia". TASS. 7 March 2021.
  101. ^ "Govt okays Russian vaccine for 'emergency use'". Dawn. 24 January 2021.
  102. ^ "Palestine has become the first country in the Middle East to register Sputnik V vaccine". RFID. 11 January 2021.
  103. ^ "Paraguay approves Russia's Sputnik V vaccine: RDIF". Reuters. 15 January 2021. Retrieved 15 January 2021.
  104. ^ أ ب ت "Sputnik V vaccine registered in Bosnia and Herzegovina's Republika Srpska". TASS. 5 February 2021. Retrieved 8 February 2021.
  105. ^ Burki TK (November 2020). "The Russian vaccine for COVID-19". The Lancet. Respiratory Medicine. 8 (11): e85–e86. doi:10.1016/S2213-2600(20)30402-1. PMC 7837053. PMID 32896274.
  106. ^ "San Marino buys the Sputnik vaccine: "First doses already in the next few days"". Unioneonline. 20 February 2021.
  107. ^ "Agencija odobrila uvoz ruske vakcine Sputnjik V u Srbiju". N1 (in الصربية). 31 December 2020.
  108. ^ "Sputnik V approved for use in Slovakia". rdif.ru. Retrieved 1 March 2021.
  109. ^ "Sri Lanka approves Russia's Sputnik V vaccine". The Hindu. 4 March 2021.
  110. ^ "Sputnik V vaccine authorized in Tunisia" (Press release). Gamaleya Center. Retrieved 30 January 2021.
  111. ^ "UAE approves Russia's Sputnik vaccine for emergency use". Khaleej Times. 21 January 2021. Retrieved 21 January 2021.
  112. ^ "Uruguay to start covid 19 Vaccination in April 2021". India Blooms.
  113. ^ "Venezuela firma contrato para la adquisición de la vacuna rusa Sputnik V" (in الإسبانية). Reuters. 29 December 2020.
  114. ^ أ ب "Vietnam approves US, Russia Covid-19 vaccines for emergency use". VnExpress. Retrieved 26 February 2021.
  115. ^ أ ب "Covid-19: Zimbabwe authorises Sputnik V, Sinovac vaccines for emergency use". news24.com. 9 March 2021.
  116. ^ أ ب ت "Angola, Congo Republic and Djibouti approve Russia's Sputnik V vaccine". Reuters. 3 March 2021.
  117. ^ "Hungarian drug regulator approves Sputnik V vaccine: website". The Moscow Times. 7 February 2021.
  118. ^ "Sputnik V registered in Kyrgyzstan". Gamaleya Center (Press release). 23 February 2021.
  119. ^ "Syria authorizes use of Sputnik-V". Roya. 22 February 2021.
  120. ^ "Turkmenistan is the first in Central Asia to have registered "Sputnik V" vaccine". Orient. 18 January 2021.
  121. ^ "Uzbekistan Certifies Russia's Sputnik Vaccine For Mass Use". Agence France-Presse (Barron's). 17 February 2021.
  122. ^ "AstraZeneca & Serum Institute of India sign licensing deal for 1 million doses of Oxford vaccine". The Economic Times. Retrieved 15 June 2020.
  123. ^ "Covid-19 vaccine: Serum Institute signs up for 100 million doses of vaccines for India, low and middle-income countries". The Financial Express. 7 August 2020.
  124. ^ Walsh N, Shelley J, Duwe E, Bonnett W (27 July 2020). "The world's hopes for a coronavirus vaccine may run in these health care workers' veins". São Paulo: CNN. Archived from the original on 3 August 2020. Retrieved 3 August 2020.
  125. ^ أ ب "Investigating a Vaccine Against COVID-19". ClinicalTrials.gov. United States National Library of Medicine. 26 May 2020. NCT04400838. Archived from the original on 11 October 2020. Retrieved 14 July 2020.
  126. ^ "A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19". EU Clinical Trials Register. European Union. 21 April 2020. EudraCT 2020-001228-32. Archived from the original on 5 October 2020. Retrieved 3 August 2020.
  127. ^ O'Reilly P (26 May 2020). "A Phase III study to investigate a vaccine against COVID-19". ISRCTN. doi:10.1186/ISRCTN89951424. ISRCTN89951424.
  128. ^ Gallagher, James; Triggle, Nick (30 December 2020). "Covid-19: Oxford-AstraZeneca vaccine approved for use in UK". BBC. Retrieved 5 March 2020.
  129. ^ قالب:Cite techreport
  130. ^ "A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19". ClinicalTrials.gov. United States National Library of Medicine. 12 May 2020. NCT04383574. Archived from the original on 23 August 2020. Retrieved 26 August 2020.
  131. ^ Sediqi, Abdul Qadir (7 February 2021). "First doses of COVID-19 vaccine arrive in Afghanistan from India". Reuters. Retrieved 24 February 2021.
  132. ^ "India donates 500,000 COVID vaccines to Afghanistan". Al Jazeera. Retrieved 24 February 2021.
  133. ^ "Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine". Reuters. 30 December 2020. Retrieved 30 December 2020.
  134. ^ "Bahrain approves Oxford/AstraZeneca coronavirus vaccine produced in India". Saudigazette. 25 January 2021. Retrieved 30 January 2021.
  135. ^ "Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use". The Daily Star. Retrieved 6 January 2021.
  136. ^ "Bangladesh approves Oxford-AstraZeneca COVID-19 vaccine". aa.com.tr. Retrieved 6 January 2021.
  137. ^ أ ب McGeever J, Fonseca P (17 January 2021). "Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin". Reuters. Retrieved 17 January 2021.
  138. ^ "La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19". Agencia EFE (in الإسبانية). 31 December 2020.
  139. ^ "Ecuador approves use of AstraZeneca vaccine for COVID-19". Reuters. 24 January 2021. Retrieved 30 January 2021.
  140. ^ "El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine". Reuters. 30 December 2020.
  141. ^ "Guyana gets first batch of COVID-19 vaccines; CARICOM Secretariat to get 100 doses". 10 February 2021. Retrieved 19 February 2021.
  142. ^ "Nurse administers first shot of AstraZeneca ( ChAdOx1 nCoV-19, ) vaccine to Brinnet Bernarai at Georgetown Public Hospital Corporation – PAHO/WHO | Pan American Health Organization". paho.org. Retrieved 19 February 2021.
  143. ^ أ ب Schmall E, Yasir S (3 January 2021). "India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other". The New York Times. Retrieved 3 January 2021.
  144. ^ "BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 AstraZeneca". Kompas.com. Retrieved 10 February 2021.
  145. ^ أ ب "Iraq approves Sinopharm, AstraZeneca vaccines". Big News Network.com. Retrieved 30 January 2021.
  146. ^ https://www.bbc.com/news/world-africa-56239136
  147. ^ https://www.voanews.com/covid-19-pandemic/kenya-receives-1m-vaccine-doses-will-distribute-health-workers-first
  148. ^ "Maldives starts training healthcare workers on COVID-19 vaccine distribution – Xinhua | English.news.cn". Xinhua News Agency. Retrieved 19 February 2021.
  149. ^ AfricaNews (26 January 2021). "Mauritius begins vaccinating frontline health workers against covid-19". Africanews. Retrieved 24 February 2021.
  150. ^ "Mexico approves AstraZeneca COVID-19 vaccine, minister says". Reuters. 5 January 2021. Retrieved 14 January 2021.
  151. ^ "Myanmar launches nationwide COVID-19 vaccination program". Xinhua News. 27 January 2021.
  152. ^ "Nepal approves AstraZeneca COVID vaccine for emergency use – government statement". Reuters. 15 January 2021.
  153. ^ "Wetin we sabi about NAFDAC approval of Oxford AstraZeneca vaccine use for Nigeria". BBC News Pidgin. Retrieved 24 February 2021.
  154. ^ "Pakistan approves AstraZeneca COVID-19 vaccine for emergency use". 16 January 2021.
  155. ^ "Philippine regulator approves emergency use of AstraZeneca vaccine". Reuters. 28 January 2021. Retrieved 28 January 2021.
  156. ^ https://www.afro.who.int/news/rwanda-receives-covid-19-vaccines-through-covax
  157. ^ أ ب "AstraZeneca and Moderna vaccines to be administered in Saudi Arabia". Gulf News. Retrieved 19 January 2021.
  158. ^ "Sri Lanka approves vaccine amid warnings of virus spread". AP NEWS. 22 January 2021. Retrieved 22 January 2021.
  159. ^ https://www.unicef.org/sudan/stories/covid-19-vaccination-sudan
  160. ^ https://www.unicef.org/press-releases/sudan-receives-first-delivery-covid-19-vaccines-over-800000-doses
  161. ^ "Suriname begins coronavirus vaccination campaign with donated doses". Reuters. 23 February 2021. Retrieved 28 February 2021.
  162. ^ "Taiwan grants emergency authorisation for AstraZeneca COVID-19 vaccine". Reuters. 20 February 2021. Retrieved 13 March 2021.
  163. ^ "Thai Food and Drug registers COVID-19 vaccine developed by AstraZeneca". Pattaya Mail. 23 January 2021.
  164. ^ https://www.togofirst.com/en/health/1602-7300-covid-19-first-vaccination-campaign-to-soon-begin
  165. ^ https://www.africanews.com/2021/03/10/uganda-starts-covid-19-vaccinations/
  166. ^ "COVID-19: AstraZeneca vaccine certified for use in Ukraine". covid.unian.info (in الإنجليزية). Retrieved 10 March 2021.
  167. ^ "Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. Retrieved 4 January 2021.
  168. ^ "Oxford University/AstraZeneca vaccine authorised by UK medicines regulator" (Press release). Department of Health and Social Care. 30 December 2020. Retrieved 30 December 2020.
  169. ^ "Conditions of Authorisation for COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. Retrieved 4 January 2021.
  170. ^ "Vietnam approves AstraZeneca COVID-19 vaccine, cuts short Communist Party congress". CNA. Retrieved 5 February 2021.
  171. ^ "Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca". World Health Organization (WHO). Retrieved 27 February 2021.
  172. ^ "AstraZeneca/Oxford Covid-19 Vaccine Gets Emergency Approval From WHO". Forbes. Retrieved 16 February 2021.
  173. ^ "AstraZeneca coronavirus vaccine approved for use in Australia by TGA". ABC News. 16 February 2021. Retrieved 16 February 2021.
  174. ^ "TGA provisionally approves AstraZeneca's COVID-19 vaccine". Therapeutic Goods Administration (TGA). 16 February 2021. Retrieved 16 February 2021.
  175. ^ "Regulatory Decision Summary – AstraZeneca COVID-19 Vaccine". Health Canada. 26 February 2021. Retrieved 26 February 2021.
  176. ^ "COVID-19 Vaccine AstraZeneca: Pending EC decision". European Medicines Agency (EMA). 28 January 2021. Retrieved 29 January 2021.
  177. ^ "EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU". European Medicines Agency (EMA) (Press release). 29 January 2021. Retrieved 29 January 2021.
  178. ^ "European Commission authorises third safe and effective vaccine against COVID-19". European Commission (Press release). 29 January 2021. Retrieved 29 January 2021.
  179. ^ أ ب "EU-Kommissionen har i dag udstedt en betinget markedsføringstilladelse til AstraZeneca COVID-19- vaccine. Tilladelsen gælder i Danmark". Lægemiddelstyrelsen (in الدانمركية). Retrieved 12 March 2021.
  180. ^ "The Icelandic Medicines Agency have issued a conditional marketing authorisation for the AstraZeneca COVID-19 vaccine". covid.is. Retrieved 12 March 2021.
  181. ^ أ ب "Malaysia's NPRA Approves AstraZeneca, Sinovac Covid-19 Vaccines". CodeBlue. 2 March 2021. Retrieved 7 March 2021.
  182. ^ أ ب Sipalan, Joseph; Donovan, Kirsten (3 March 2021). "Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use". Reuters. Retrieved 7 March 2021.
  183. ^ "The European Commission has now approved the AstraZeneca COVID-19 vaccine. This means that the vaccine is approved for use in Norway". vg. Retrieved 12 March 2021.
  184. ^ Kim, Han-joo (10 February 2021). "S. Korea approves AstraZeneca's COVID-19 vaccine for all adults". Yonhap News Agency. Retrieved 10 February 2021.
  185. ^ Maresca, Thomas (10 February 2021). "South Korea approves AstraZeneca COVID-19 vaccine". United Press International. Retrieved 10 February 2021.
  186. ^ أ ب Chen W, Al Kaabi N (18 July 2020). "A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)". Chinese Clinical Trial Registry. Retrieved 15 August 2020.
  187. ^ Xia, Shengli; Zhang, Yuntao; Wang, Yanxia; Wang, Hui; Yang, Yunkai; Gao, George; et al. (15 October 2020). "Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial". The Lancet Infectious Diseases. 21 (1): 39–51. doi:10.1016/S1473-3099(20)30831-8. PMC 7561304. PMID 33069281.
  188. ^ Elbahrawy, Farah; Lyu, Dong; Omar, Abeer; Che, Claire; Paton, James (9 December 2020). "China State-Backed Covid Vaccine Has 86% Efficacy, UAE Says". Bloomberg News. Retrieved 5 March 2020. CNBG's vaccine can be transported and stored at normal refrigerated temperatures.
  189. ^ Biannchi, Walter (21 February 2021). "Argentina approves Sinopharm COVID-19 vaccine for emergency use". Reuters. Retrieved 23 February 2021.
  190. ^ "Bolivia begins inoculation with Sinopharm jabs | The Star". The Star. Malaysia. Retrieved 28 February 2021.
  191. ^ Rinith T (4 February 2021). "Health Ministry grants Emergency Use Authorization to China's Sinopharm vaccine". Khmer Times. Retrieved 4 February 2021.
  192. ^ "Dominica: Melissa Skerrit receives the Sinopharm COVID-19 vaccine". WIC News. 4 March 2021. Retrieved 7 March 2021.
  193. ^ "Egypt licenses China's Sinopharm COVID-19 vaccine for emergency use: health minister – Xinhua | English.news.cn". Xinhua News Agency.
  194. ^ "Sinopharm vaccine rollout starts this weekend". Stabroek News. 6 March 2021. Retrieved 7 March 2021.
  195. ^ "Hungary signs deal for Chinese Sinopharm's COVID-19 vaccine, first in EU". National Post.
  196. ^ "Iran Launches Phase Two of Mass Inoculation Campaign". Financial Tribune. 22 February 2021. Retrieved 23 February 2021.
  197. ^ "First batch of Chinese Sinopharm vaccine arrives in Jordan". Roya News. Retrieved 9 January 2021.
  198. ^ Crean, Rosabel. "China donates 50,000 doses of Sinopharm vaccine to Lebanon | News , Lebanon News | THE DAILY STAR". Daily Star. Retrieved 2 March 2021.
  199. ^ "Macau receives first batch of COVID-19 vaccines". IAG. 7 February 2021. Retrieved 24 February 2021.
  200. ^ "Covid-19: Morocco authorizes use of the Sinopharm vaccine". en.yabiladi.com.
  201. ^ Reuters Staff (6 March 2021). "Mozambique expects to vaccinate 16 million against coronavirus by 2022". Reuters (in الإنجليزية). Retrieved 7 March 2021. {{cite web}}: |author= has generic name (help)
  202. ^ Poudel, Arjun. "China's Shinopharm vaccine gets emergency use authorisation in Nepal". Kathmandu Post. Retrieved 19 February 2021.
  203. ^ Shahzad A (19 January 2021). "Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use". Reuters.
  204. ^ "Peru grants 'exceptional' approval for Sinopharm COVID-19 vaccine – government sources". Reuters. 27 January 2021.
  205. ^ Asala, Kizzi. "Senegal Kicks Off COVID-19 Vaccination Campaign with China's Sinopharm". Africanews. Retrieved 23 February 2021.
  206. ^ "Serbia Becomes First European Nation To Use China's Sinopharm Vaccine". RadioFreeEurope/RadioLiberty.
  207. ^ Sequera, Vivian (1 March 2021). "Venezuela approves use of China's Sinopharm coronavirus vaccine". Reuters. Retrieved 2 March 2021.
  208. ^ Mutsaka, Farai (18 February 2021). "Zimbabwe starts administering China's Sinopharm vaccines". The Star. Retrieved 20 February 2021.
  209. ^ "Bahrain approves China's Sinopharm coronavirus vaccine". Arabian Business Industries. 13 December 2020.
  210. ^ Kuo L. "China approves Sinopharm coronavirus vaccine, the country's first for general use". The Washington Post.
  211. ^ "President Ramkalawan and First Lady receives second dose SinoPharm Vaccine". statehouse.gov.sc. Retrieved 5 February 2021.
  212. ^ Wee S (9 December 2020). "Chinese Covid-19 Vaccine Gets Key Push, but Doubts Swirl". The New York Times. Retrieved 12 December 2020.
  213. ^ "Coronavirus: UAE authorises emergency use of vaccine for frontline workers". The National. Retrieved 24 November 2020.
  214. ^ أ ب "Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19) (Renqiu)". ClinicalTrials.gov. United States National Library of Medicine. 12 May 2020. NCT04383574. Archived from the original on 11 October 2020. Retrieved 14 July 2020.
  215. ^ "Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)". ClinicalTrials.gov. United States National Library of Medicine. 2 July 2020. NCT04456595. Archived from the original on 11 October 2020. Retrieved 3 August 2020.
  216. ^ PT. Bio Farma (10 August 2020). "A Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-COV-2 inactivated vaccine in healthy adults aged 18–59 years in Indonesia". Registri Penyakit Indonesia. Retrieved 15 August 2020.
  217. ^ "Sinovac says COVID-19 vaccine effective in preventing hospitalization, death". Reuters. 5 February 2021. Retrieved 5 March 2021.
  218. ^ Tan, Yvette (14 January 2021). "Covid: What do we know about China's coronavirus vaccines?". BBC. Retrieved 5 March 2020.
  219. ^ Aliyev J. "Azerbaijan kicks off COVID-19 vaccination". Anadolu Agency. Retrieved 7 February 2021.
  220. ^ "Bolívia autoriza uso de vacinas Sputnik V e CoronaVac contra covid-19". noticias.uol.com.br (in البرتغالية البرازيلية). Retrieved 6 January 2021.
  221. ^ Chanritheara, Torn. "Cambodia Approves AstraZeneca and Sinovac Vaccines for COVID-19 Emergency Use". Cambodianess. Retrieved 12 February 2021.
  222. ^ "Chile aprueba el uso de emergencia de la vacuna china de Sinovac contra covid-19". France 24. 20 January 2021. Retrieved 30 January 2021.
  223. ^ Aliyev J. "Colombia approves emergency use of CoronaVac vaccine". Anadolu Agency. Retrieved 7 February 2021.
  224. ^ "Anticovid vaccines run out as Dominican Republic awaits arrival of more doses" (in الإنجليزية). DominicanToday. Retrieved 10 March 2021.
  225. ^ "Ecuador signs agreement with Sinovac for 2 million COVID-19 vaccine: minister". National Post. Retrieved 26 February 2021.
  226. ^ "Use of Sinovac vaccine authorised". Government of Hong Kong. 18 February 2021. Retrieved 19 February 2021.
  227. ^ خطأ استشهاد: وسم <ref> غير صحيح؛ لا نص تم توفيره للمراجع المسماة StraitsTimes20210111
  228. ^ "BPOM Grants Emergency Use Authorization for Sinovac Vaccine". Tempo. 11 January 2021. Retrieved 11 January 2021.
  229. ^ أ ب ت Liu R (6 February 2021). "China approves Sinovac Biotech COVID-19 vaccine for general public use". Reuters. Retrieved 7 February 2021.
  230. ^ أ ب Barrera, Adriana (11 February 2021). "Mexico approves China's CanSino and Sinovac COVID-19 vaccines". Reuters. Retrieved 11 February 2021.
  231. ^ "Philippines approves Sinovac's COVID-19 vaccine for emergency use". Reuters. 22 February 2021.
  232. ^ Thepgumpanat, Panarat (22 February 2021). "Thailand allows emergency use of Sinovac's COVID-19 vaccine". Reuters. Retrieved 23 February 2021.
  233. ^ "Tunisia approva vaccino cinese Sinovac" (in الإيطالية). Agenzia Nazionale Stampa Associata (in Italian). 5 March 2021. Retrieved 7 March 2021.
  234. ^ "Turkey to begin COVID-19 vaccine jabs by this weekend". Anadolu. 11 January 2021. Retrieved 11 January 2021.
  235. ^ Zinets, Natalia (9 March 2021). "Ukraine approves China's Sinovac COVID-19 vaccine". Reuters (in الإنجليزية). Retrieved 10 March 2021.
  236. ^ "A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19". ClinicalTrials.gov. United States National Library of Medicine. 14 July 2020. NCT04470427. Archived from the original on 11 October 2020. Retrieved 27 July 2020.
  237. ^ Palca J (27 July 2020). "COVID-19 vaccine candidate heads to widespread testing in U.S." NPR. Archived from the original on 11 October 2020. Retrieved 27 July 2020.
  238. ^ "Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)". ClinicalTrials.gov. United States National Library of Medicine. 16 March 2020. NCT04283461. Retrieved 5 March 2021.
  239. ^ "WHO experts issue recommendations on Moderna COVID-19 vaccine". Reuters. Geneva. 26 January 2021. Retrieved 5 March 2021.
  240. ^ قالب:Cite techreport
  241. ^ "Regulatory Decision Summary – Moderna COVID-19 Vaccine". Health Canada, Government of Canada. 23 December 2020. Retrieved 23 December 2020.
  242. ^ "Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel". modernatx.com. 4 January 2021. Retrieved 4 January 2021.
  243. ^ "Singapore becomes first in Asia to approve Moderna's COVID-19 vaccine". Reuters. 3 February 2021. Retrieved 3 February 2021.
  244. ^ "Swissmedic grants authorisation for the COVID-19 vaccine from Moderna" (Press release). Swiss Agency for Therapeutic Products (Swissmedic). 12 January 2020. Retrieved 12 January 2020.
  245. ^ "Information for Healthcare Professionals on COVID-19 Vaccine Moderna". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Retrieved 8 January 2021.
  246. ^ "Conditions of Authorisation for COVID-19 Vaccine Moderna". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Retrieved 9 January 2021.
  247. ^ "FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine". U.S. Food and Drug Administration (FDA) (Press release). Retrieved 18 December 2020.
  248. ^ Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, et al. (December 2020). "The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine – United States, December 2020" (PDF). MMWR. Morbidity and Mortality Weekly Report. 69 (5152): 1653–56. doi:10.15585/mmwr.mm695152e1. PMID 33382675. S2CID 229945697.
  249. ^ "COVID-19 Vaccine Moderna EPAR". European Medicines Agency (EMA). Retrieved 20 January 2021.
  250. ^ "European Commission authorises second safe and effective vaccine against COVID-19". European Commission (Press release). Retrieved 6 January 2021.
  251. ^ "EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU" (Press release). European Medicines Agency. 6 January 2021. Retrieved 6 January 2021.
  252. ^ "COVID-19 Vaccine Moderna". Union Register of medicinal products. Retrieved 14 January 2021.
  253. ^ أ ب "Endnu en vaccine mod COVID-19 er godkendt af EU-Kommissionen". Lægemiddelstyrelsen (in الدانمركية). Retrieved 7 January 2021.
  254. ^ "COVID-19: Bóluefninu COVID-19 Vaccine Moderna frá hefur verið veitt skilyrt íslenskt markaðsleyfi". Lyfjastofnun (in الأيسلندية). Retrieved 7 January 2021.
  255. ^ "Status på koronavaksiner under godkjenning per 6. januar 2021". Statens legemiddelverk (in النرويجية بوكمال). Retrieved 7 January 2021.
  256. ^ "A Study of Ad26.COV2.S in Adults". ClinicalTrials.gov. 4 August 2020. Archived from the original on 16 September 2020. Retrieved 23 August 2020.
  257. ^ "A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants". ClinicalTrials.gov. US National Library of Medicine. Archived from the original on 26 September 2020.
  258. ^ قالب:Cite techreport
  259. ^ أ ب Ledford H (29 January 2021). "J&J's one-shot COVID vaccine offers hope for faster protection". Nature. doi:10.1038/d41586-021-00119-7. PMID 33526898.
  260. ^ "Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use". Reuters. 25 February 2021. Retrieved 25 February 2021.
  261. ^ "Bahrain becomes 1st nation to grant J&J shot emergency use". ABC News. 25 February 2021. Retrieved 25 February 2021.
  262. ^ "Johnson & Johnson COVID-19 vaccine becomes 4th to receive Health Canada approval | CBC News" (in الإنجليزية الأمريكية). Canadian Broadcasting Corporation. Retrieved 5 March 2021.
  263. ^ "Coronavirus: South Africa rolls out vaccination programme". BBC News. 17 February 2021. Retrieved 19 February 2021.
  264. ^ "FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine". U.S. Food and Drug Administration (FDA) (Press release). 27 February 2021. Retrieved 27 February 2021.
  265. ^ https://www.fda.gov/media/146303/download
  266. ^ "WHO approves J&J's COVID-19 vaccine for emergency listing". Channel News Asia. March 13, 2021. Retrieved March 13, 2021.
  267. ^ https://www.jnj.com/johnson-johnson-single-shot-covid-19-vaccine-granted-conditional-marketing-authorization-by-european-commission
  268. ^ "European Commission authorises fourth safe and effective vaccine against COVID-19". European Commission (Press release). 11 March 2021.
  269. ^ أ ب "EU-Kommissionen har i dag udstedt en betinget markedsføringstilladelse til Johnson & Johnsons COVID-19- vaccine. Tilladelsen gælder i Danmark". Lægemiddelstyrelsen (in الدانمركية). Retrieved 12 March 2021.
  270. ^ "The Icelandic Medicines Agency have issued a conditional marketing authorisation". covid.is. Retrieved 12 March 2021.
  271. ^ "The European Commission has now approved the Johnson & Johnson vaccine. This means that the vaccine is approved for use in the EU and Norway". vg. Retrieved 12 March 2021.
  272. ^ "Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers". ClinicalTrials.gov. NCT04471519.
  273. ^ أ ب "Covishield and Covaxin: What we know about India's Covid-19 vaccines". BBC. 4 March 2021. Retrieved 5 March 2020. The two doses are given four weeks apart. The vaccine can be stored at 2C to 8C.
  274. ^ "An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers". ClinicalTrials.gov. NCT04641481. Retrieved 26 November 2020.
  275. ^ "Iran issues permit for emergency use for three other COVID-19 vaccines: Official". IRNA English (in الإنجليزية). 17 February 2021.
  276. ^ Manral, Karan (4 March 2021). "Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine". Hindustan Times. Retrieved 6 March 2021.{{cite news}}: CS1 maint: url-status (link)
  277. ^ Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, et al. (August 2020). "Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial". Lancet. 396 (10249): 479–88. doi:10.1016/s0140-6736(20)31605-6. ISSN 0140-6736. PMC 7836858. PMID 32702299. {{cite journal}}: Unknown parameter |lay-url= ignored (help)
  278. ^ أ ب Peshimam, Gibran; Farooq, Umar (8 February 2021). "CanSinoBIO's COVID-19 vaccine 65.7% effective in global trials, Pakistan official says". Reuters. Islamabad. Retrieved 5 March 2021. its single-dose regimen and normal refrigerator storage requirement could make it a favourable option for many countries
  279. ^ "CanSino's COVID-19 vaccine approved for military use in China". Nikkei Asia. Retrieved 24 December 2020.
  280. ^ "More Than 2.7 Million People Have Gotten Vaccines: Covid-19 Tracker". Bloomberg L.P. Retrieved 24 December 2020.
  281. ^ Shahzad, Asif (12 February 2021). "Pakistan approves Chinese CanSinoBIO COVID vaccine for emergency use". Reuters. Retrieved 12 February 2021.
  282. ^ أ ب ت "Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (EpiVacCorona)". ClinicalTrials.gov. United States National Library of Medicine. 22 September 2020. NCT04368988. Retrieved 16 November 2020.
  283. ^ Benedyczak, Jakub (12 February 2021). Russia's Problems in the Vaccine Race. Polish Institute of International Affairs. Archived from the original. You must specify the date the archive was made using the |archivedate= parameter. https://pism.pl/publications/Russias_Problems_in_the_Vaccine_Race. Retrieved on 6 March 2021. "the Sputnik V and EpiVacCorona can be transported and stored at temperatures of +2 to + 8° C" 
  284. ^ "О регистрации вакцины ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора "ЭпиВакКорона"". Rospotrebnadzor (in الروسية). 14 October 2020.
  285. ^ "Russia's EpiVacCorona vaccine post-registration trials started". The Pharma Letter. 18 November 2020.
  286. ^ "Turkmenistan registers vaccines for the prevention of infectious diseases". Turkmenistan Today. 29 January 2021.
  287. ^ "Russian vaccine "EpiVacCorona" was registered in Turkmenistan". EN24. 29 January 2021.
  288. ^ "Briefing with Deputy Prime Minister Tatyana Golikova, Health Minister Mikhail Murashko and Head of Rospotrebnadzor Anna Popova". Government of Russia. 18 January 2021. Retrieved 20 February 2021.
  289. ^ Ryumin, Alexander (20 February 2021). "Russia registers its third COVID-19 vaccine CoviVac". TASS. Moscow. Retrieved 6 March 2021.
  290. ^ أ ب Ivanova, Polina (8 February 2021). "Russia approves its third COVID-19 vaccine, CoviVac". Reuters. Moscow. Retrieved 5 March 2021. The CoviVac shot is given in two doses, 14 days apart. It is transported and stored at normal fridge temperatures, of 2 to 8 degrees Celsius (35.6 to 46.4 Fahrenheit), Deputy Prime Minister Tatiana Golikova said in a government briefing in January.
  291. ^ "Russia approves its third COVID-19 vaccine, CoviVac". Reuters. 20 February 2021.
  292. ^ خطأ استشهاد: وسم <ref> غير صحيح؛ لا نص تم توفيره للمراجع المسماة london
  293. ^ أ ب "A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19". ClinicalTrials.gov.
  294. ^ "China's CAS COVID-19 vaccine induces immune response in mid-stage tests". Reuters. Beijing. 23 December 2020. Retrieved 8 March 2021.
  295. ^ Mamatkulov, Mukhammadsharif (1 March 2021). "Uzbekistan approves Chinese-developed COVID-19 vaccine". Reuters. Retrieved 2 March 2021.
  296. ^ "Uzbekistan certifies Chinese vaccine to fight against COVID-19". China Daily. 2 March 2021. Retrieved 8 March 2021.


خطأ استشهاد: وسوم <ref> موجودة لمجموعة اسمها "lower-alpha"، ولكن لم يتم العثور على وسم <references group="lower-alpha"/>

تمّ الاسترجاع من "https://www.marefa.org/w/index.php?title=مقارنة_لقاحات_كوڤيد-19&oldid=2306616"